Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
At a 70% price reduction, GLP-1RA is predicted to be cost-effective compared to non-SGLT2i standard-of-care therapies (cost-effectiveness ratio [CER] of $22,700)
Our care team verifies your coverage and matches you with a provider that accepts it
If your B12 level is found to be below normal, replacing that vitamin B12 is very important, explains family physician Kenneth Goodman, MD
Higher cAMP activates protein kinase A
US$ 23.33
US$ 26.91
US$ 21.96
US$ 22.48
US$ 27.95
